New Patient Appointment or 214-645-8300

Justin Grodin, M.D., M.P.H.

Three parallel advances usher in new age of cardiac amyloidosis care

Cardiac amyloidosis was once considered untreatable. Now, we have effective treatments, less invasive diagnostic tests, and a growing body of research in this complex disease.

Justin Grodin, M.D., M.P.H.

March 24, 2023

New drugs for cardiac amyloidosis provide hope for patients

For decades, there were no FDA-approved treatments for cardiac amyloidosis in the U.S. But in the last two years, two new therapies were approved for cardiac- and nerve-related ATTR. In this week's MedBlog, UT Southwestern discusses these therapies and what they mean for North Texas patients.

Justin Grodin, M.D., M.P.H.

July 31, 2019